Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT01500083 · COMPLETED
Trial details
- NCT number
- NCT01500083
- Sponsor
- Lundbeck Canada Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-06-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.